World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   2624 records for 887 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingCTRI/2014/12/005334
Phase III multicenter, double-blind, randomized, parallel-group study to evaluate safety and efficacy of Hercules plus Taxane Herceptin® plus Taxane as First Line therapy in Her2-Positive Metastatic Breast cancer.
30-12-2014
RecruitingSLCTR/2014/037
A Study of the Safety and Efficacy of MK-0431A XR, a Fixed-Dose Combination Tablet of Sitagliptin and Extended-Release Metformin in Pediatric Participants aged 10-17 years With Type 2 Diabetes Mellitus
2014-12-24
RecruitingNCT02321436
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
17/12/2014
Not RecruitingCTRI/2014/12/005240
Study to assess antibiotic resistance in blood stream infections in developing countries
02-12-2014
Not recruitingNCT02303444
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
25/11/2014
Not recruitingNCT02306681
A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes
12/11/2014
Not recruitingNCT02287584
Confirmatory Study of DSP-5423P in Patients With Schizophrenia
06/11/2014
AuthorisedEUCTR2014-002275-28-FI
Comparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02296138Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.19/11/2014
AuthorisedEUCTR2014-002275-28-PTComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.10/11/2014
AuthorisedEUCTR2014-002275-28-NLComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.18/11/2014
AuthorisedEUCTR2014-002275-28-HUComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.19/11/2014
AuthorisedEUCTR2014-002275-28-ATComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.27/11/2014
AuthorisedEUCTR2014-002275-28-DKComparing the efficacy of tiotropium + olodaterol (5/5 µg) fixed dose combination (FDC) over tiotropium 5µg in reducing moderate to severe exacerbations in patients with severe to very severe Chronic Obstructive Pulmonary Disease.13/11/2014
28/10/2014
RecruitingNCT02280330
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
27/10/2014
AuthorisedEUCTR2014-002694-11-HU
A late stage clinical trial to investigate the efficacy and safety of AZD9291 versus Gefitinib or Erlotinib in patients with locally advanced or metastatic Non-Small Cell Lung Cancer
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02296125AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer22/10/2014
18/10/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history